Cary Gross, MD
Professor of Medicine (General Medicine) and of Epidemiology (Chronic Diseases)Cards
About
Titles
Professor of Medicine (General Medicine) and of Epidemiology (Chronic Diseases)
Founder and Director, Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, Yale School of Medicine; Director, National Clinician Scholars Program
Biography
Dr. Cary Gross is a Professor of Medicine and Public Health, and Director of the National Clinician Scholars Program at Yale. Dr. Gross completed his residency in Internal Medicine at New York Hospital-Cornell Medical Center and served as chief medical resident at Memorial Sloan-Kettering Cancer Center the following year. His research addresses comparative effectiveness, quality, and health equity, with a focus on cancer prevention and treatment. He aims to use real-world research to generate knowledge that will inform change in clinical care and health policy. He is a founding Director of Yale’s Cancer Outcomes Public Policy and Effectiveness Research Center (COPPER). His research has been supported by the National Cancer Institute, the American Cancer Society, among others. As a former Robert Wood Johnson Foundation Clinical Scholar, Dr. Gross has advanced training in biostatistics, epidemiology, research ethics, and outcomes research. Follow him on twitter: @cpgYale
Appointments
General Internal Medicine
ProfessorPrimaryChronic Disease Epidemiology
ProfessorSecondaryInstitution for Social and Policy Studies
ProfessorSecondary
Other Departments & Organizations
- Cancer Prevention and Control
- Center for Outcomes Research & Evaluation (CORE)
- Chronic Disease Epidemiology
- COPPER Center
- General Internal Medicine
- Institution for Social and Policy Studies
- Internal Medicine
- MHS-AHSR Program Leadership
- National Clinician Scholars Program
- WHRY Pilot Project Program Investigators
- Women's Health Research at Yale
- Yale Cancer Center
- Yale Medicine
- Yale School of Public Health
- Yale-New Haven Hospital Primary Care Center
Education & Training
- Fellow
- Johns Hopkins School of Medicine (1999)
- Chief Resident
- Memorial Sloan-Kettering Cancer Center (1997)
- Resident
- New York Hospital, Cornell Medical Center (1996)
- Intern
- New York Hospital, Cornell Medical Center (1994)
- MD
- New York University School of Medicine (1993)
- BA
- Johns Hopkins University (1989)
Research
Overview
I am the Director of the COPPER Center at Yale, which aims to improve cancer care and to decrease the burden of cancer on individual patients and society, and to increase equity and patient-centeredness in cancer care. The Center is comprised of researchers and clinicians from across the Yale Schools of Medicine (General Medicine, Geriatrics, Oncology, Radiation Oncology, Dermatology, and Pediatrics), Public Health, and Nursing. We also provide training and mentorship to the next generation of cancer policy and outcomes researchers. Please see the COPPER website for a full description of the team and our work (http://copper.yale.edu/).
I have received NIH-funding from 2002 through the present time, with grants supporting the investigation of barriers to clinical trial enrollment, the impact of non-cancer illnesses on older persons with cancer, and the dissemination of new approaches to cancer screening and treatment into clinical practice.Currently, my collaborators and I are recipients of an NCI Provocative Questions grant, which aims to apply the concept of “social contagion” to cancer practice, shedding new light on the role of physicians and physician patient-sharing networks in the adoption of unproven technologies and the abandonment of proven ineffective treatments in cancer care.
Our recent grant through the American Cancer Society explores trends in breast cancer screening from both a clinical and policy perspective. Partnering with the Blue Cross Blue Shield Alliance for Health Research, we are assessing the association between state breast density legislation and the adoption of new breast imaging modalities, as well as evaluating the effectiveness of these newer approaches to breast cancer screening.
I am particularly interested in cancer in older persons. Cancer is an aging-related disease, and elderly cancer patients tend to have worse outcomes than their younger counterparts. This is likely due, at least in part, to the myriad of non–cancer problems that tend to accrue with age. To provide greater clarity for patient and provider decision-making, we are exploring the manner in which non–cancer chronic illnesses and geriatric syndromes affect the care and outcomes of older patients with colorectal cancer. We are using a large population-based cohort of patients with cancer derived from administrative data, and in a separate study, COPPER is participating in a prospective cohort study of older patients with cancer as part of the Cancer in Aging Research Group (CARG).
Medical Subject Headings (MeSH)
Academic Achievements & Community Involvement
Clinical Care
Overview
Clinical Specialties
Board Certifications
Internal Medicine
- Certification Organization
- AB of Internal Medicine
- Latest Certification Date
- 2016
- Original Certification Date
- 1996
Yale Medicine News
News & Links
News
- November 22, 2024
More Patients Opting for Close Monitoring of Early-stage Prostate Cancer
- October 14, 2024Source: JAMA Internal Medicine
Physicians, the Homelessness Crisis, and Public Health—All Hands on Deck
- October 07, 2024
Dr. Cary Gross on Yale Cancer Answers: Health Equity and Cancer Prevention
- October 03, 2024
Study Reveals Disparities in Colorectal Cancer Screening